Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma

J Dtsch Dermatol Ges. 2016 Mar;14(3):298-301. doi: 10.1111/ddg.12751. Epub 2016 Jan 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis*
  • Drug Eruptions / etiology
  • Drug Eruptions / therapy
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / chemically induced*
  • Lupus Erythematosus, Systemic / diagnosis*
  • Lupus Erythematosus, Systemic / therapy
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Middle Aged
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Rituximab